Literature DB >> 16364800

Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging.

Margaret A Wheatley1, Flemming Forsberg, Neal Dube, Mihir Patel, Brian E Oeffinger.   

Abstract

Ultrasound contrast agents (CA) are generally micron-sized stabilized gas bubbles, injected IV. However, to penetrate beyond the vasculature and accumulate in targets such as tumors, CA must be an order of magnitude smaller. We describe a method of achieving nanometer-sized, surfactant-stabilized CA by differential centrifugation. High g force was shown to destroy bubble integrity. Optimal conditions (300 rpm for 3 min) produced an agent with a mean diameter of 450 nm, which gave 25.5 dB enhancement in vitro at a dose of 10 microL/mL, with a 13 min half-life. In vivo, the CA produced excellent power Doppler and grey-scale pulse inversion harmonic images at low acoustic power when administered. In vivo dose-response curves obtained in three rabbits showed enhancement between 20 and 25 dB for dosages above 0.025 mL/kg. These results encourage further investigation of the possible diagnostic and therapeutic benefits of using nanoparticles as CA, including passive targeting and accumulation in tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16364800     DOI: 10.1016/j.ultrasmedbio.2005.08.009

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  19 in total

Review 1.  Ultrasound imaging beyond the vasculature with new generation contrast agents.

Authors:  Reshani H Perera; Christopher Hernandez; Haoyan Zhou; Pavan Kota; Alan Burke; Agata A Exner
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-01-08

2.  Synthesis of nanobubbles for improved ultrasound tumor-imaging applications.

Authors:  Juanjuan Zhang; Lunshou Wei; Yilin Zhao
Journal:  3 Biotech       Date:  2019-12-09       Impact factor: 2.406

3.  Preserving enhancement in freeze-dried contrast agent ST68: Examination of excipients.

Authors:  Carl Solis; Flemming Forsberg; Margaret A Wheatley
Journal:  Int J Pharm       Date:  2010-06-09       Impact factor: 5.875

4.  Development of an ultrasound sensitive oxygen carrier for oxygen delivery to hypoxic tissue.

Authors:  John R Eisenbrey; Lorenzo Albala; Michael R Kramer; Nick Daroshefski; David Brown; Ji-Bin Liu; Maria Stanczak; Patrick O'Kane; Flemming Forsberg; Margaret A Wheatley
Journal:  Int J Pharm       Date:  2014-11-18       Impact factor: 5.875

5.  Bursting Microbubbles: How Nanobubble Contrast Agents Can Enable the Future of Medical Ultrasound Molecular Imaging and Image-Guided Therapy.

Authors:  Agata A Exner; Michael C Kolios
Journal:  Curr Opin Colloid Interface Sci       Date:  2021-05-02       Impact factor: 8.209

6.  Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.

Authors:  Hanping Wu; Nicolas G Rognin; Tianyi M Krupka; Luis Solorio; Hiroki Yoshiara; Gilles Guenette; Christopher Sanders; Naohisa Kamiyama; Agata A Exner
Journal:  Ultrasound Med Biol       Date:  2013-08-09       Impact factor: 2.998

Review 7.  Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects.

Authors:  Sijumon Kunjachan; Josef Ehling; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  Chem Rev       Date:  2015-07-13       Impact factor: 60.622

Review 8.  Imaging and cancer: a review.

Authors:  Leonard Fass
Journal:  Mol Oncol       Date:  2008-05-10       Impact factor: 7.449

9.  The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging.

Authors:  Wen Bin Cai; Heng Li Yang; Jian Zhang; Ji Kai Yin; Yi Lin Yang; Li Jun Yuan; Li Zhang; Yun You Duan
Journal:  Sci Rep       Date:  2015-09-03       Impact factor: 4.379

Review 10.  Improving the performance of phase-change perfluorocarbon droplets for medical ultrasonography: current progress, challenges, and prospects.

Authors:  Paul S Sheeran; Paul A Dayton
Journal:  Scientifica (Cairo)       Date:  2014-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.